While the dollar amount is not massive relative to market cap, the fact that all three named executives sold simultaneously—especially the CEO—suggests a lack of near-term conviction. Traders should watch for potential softness in upcoming earnings or pipeline updates.
Price Chart
Executive Summary
Three corporate insiders at Cytokinetics sold shares in the past week, totaling $964K in open-market dispositions. CEO Robert Blum accounted for over half the volume, selling $500K worth of stock, while two other executives sold smaller amounts. All trades occurred at prices between $65.00 and $66.63.
Key Financial Metrics
Key Facts
- CEO Robert Blum sold $500K in stock, representing the largest single transaction in the cluster.
- Two other executives — EVPs — sold a combined $465K in shares over the same period.
- Total open-market selling by insiders amounts to $964K, or approximately 0.012% of the company's $8.1B market cap.
- All sales occurred at market prices between $65.00 and $66.63, indicating no block discount or distressed sale.
- No open-market purchases were reported; all transactions were sales or non-cash derivative exercises.
Financial Impact
$964,000 in insider selling over 7 days
Risk Factors
- Perception of insider pessimism, particularly given CEO participation.
- Potential for negative sentiment ripple in a high-beta biotech stock despite modest dollar volume.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CYTK-1775679566910 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $69.31 $67.59 | ▲ +2.48% | ▲ +4.59% | $65.60 (+5.35%) |
Sep 11, 2026 20d ago | Insider Cluster | $72.45 $67.56 | ▼ −6.75% | ▼ −6.86% | $65.60 (−9.45%) |
Sep 1, 2026 4w ago | Insider Cluster | $71.40 $74.11 | ▲ +3.80% | ▲ +3.71% | $65.60 (−8.12%) |
Aug 31, 2026 4w ago | Insider Cluster | $71.40 $74.11 | ▲ +3.80% | ▲ +3.71% | $65.60 (−8.12%) |
Aug 29, 2026 4w ago | Press Release | $70.91 $75.35 | ▲ +6.26% | ▲ +6.40% | $65.60 (−7.49%) |
Aug 28, 2026 5w ago | 8-K | $72.09 $72.72 | ▲ +0.87% | ▲ +0.76% | $65.60 (−9.00%) |
Jul 30, 2026 9w ago | Insider Cluster | $80.42 $81.37 | ▲ +1.18% | ▼ −2.44% | $65.60 (−18.43%) |
Jul 27, 2026 9w ago | Insider Cluster | $80.62 $77.13 | ▼ −4.33% | ▼ −5.40% | $65.60 (−18.63%) |
Jul 23, 2026 10w ago | Press Release | $80.74 $80.42 | ▼ −0.40% | ▼ −0.77% | $65.60 (−18.75%) |
Jul 14, 2026 11w ago | Insider Cluster | $81.93 $79.11 | ▼ −3.44% | ▼ −2.15% | $65.60 (−19.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access